CBLL

CeriBell, Inc.

55
Fundamentals48/ 100
Valuation50/ 100
Upside potential60/ 100
Risk potential30/ 100

CBLL's outlook is improving, though it still trails on the overall score.

UNH

UnitedHealth Group Incorporated

62
Fundamentals51/ 100
Valuation56/ 100
Upside potential71/ 100
Risk potential15/ 100

UNH has the edge over CBLL overall, supported by lower modeled downside and stronger modeled upside.

CBLL Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

CBLL's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

UNH Fundamentals

MetricStatus
Stable
Stable
Healthy
Healthy

UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.

CBLL PE Valuation

CBLL has no meaningful PE right now: it lost money over the past year.

UNH PE Valuation

CHEAPFAIREXPENSIVE10x21x31x42x
CHEAPFAIREXPENSIVE10x21x31x42x
LevelPEPriceVs current
Forward18x$405—
Cheap19x$325-20%
Fair23x$410+1.2%
Current23x$405—
Expensive30x$526+30%

Historical ranges are pointers, not guarantees.

UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.

CBLL Forward outlook

MetricOutlook
--
Losses steady
Strong growth
Strongly improving
Limited
Low

Analysts expect CBLL's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.

UNH Forward outlook

MetricOutlook
Strongly improving
Strong growth
Stable
Improving
Moderate
Low

Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.

CBLL Risk to reward

ScenarioChangePrice
Upside+44%$38.02
Downside-30%$18.49

Calculated from the latest close: $26.35 on Nov 12.

CBLL trails UNH on modeled risk to reward, with less potential upside relative to its potential downside.

UNH Risk to reward

ScenarioChangePrice
Upside+36%$550.65
Downside-15%$346.07

Calculated from the latest close: $405.13 on Nov 12.

UNH has a better modeled risk to reward balance than CBLL, with more potential upside relative to its potential downside.

CBLL Earnings Per Share

Q4 2023: $-1.25Q1 2024: $-1.20Q2 2024: $-1.16Q3 2024: $-2.71Q4 2025: $-1.46Q1 2026: $-1.62Q2 2026: $-1.75Q3 2026: $-1.93
Q4 2023: $-1.25Q1 2024: $-1.20Q2 2024: $-1.16Q3 2024: $-2.71Q4 2025: $-1.46Q1 2026: $-1.62Q2 2026: $-1.75Q3 2026: $-1.93

CBLL is still losing money, but less than at its worst: $1.93 per share over the past year, against $2.71 at its worst in late 2024.

UNH Earnings Per Share

Q4 2023: $23.86Q1 2024: $16.38Q2 2024: $15.10Q3 2024: $15.37Q4 2024: $15.51Q1 2025: $23.89Q2 2025: $23.09Q3 2025: $19.17Q4 2025: $13.23Q1 2026: $13.28Q2 2026: $15.58Q3 2026: $17.55Forward: $22.65
Q4 2023: $23.86Q1 2024: $16.38Q2 2024: $15.10Q3 2024: $15.37Q4 2024: $15.51Q1 2025: $23.89Q2 2025: $23.09Q3 2025: $19.17Q4 2025: $13.23Q1 2026: $13.28Q2 2026: $15.58Q3 2026: $17.55Forward: $22.65
QuarterTTM EPSYoY
Forward$22.65+29%
Q3 2026$17.55-8.5%
Q2 2026$15.58-33%
Q1 2026$13.28-44%
Q4 2025$13.23-15%
Q3 2025$19.17+25%
Q2 2025$23.09+53%
Q1 2025$23.89+46%
Q4 2024$15.51-35%

UNH has the edge over CBLL in the latest year-over-year earnings comparison.

CBLL Quarterly Revenue

Q4 2023: $13MQ1 2024: $15MQ2 2024: $15MQ3 2024: $17MQ4 2024: $19MQ1 2025: $20MQ2 2025: $21MQ3 2025: $23MQ4 2025: $25MQ1 2026: $26MQ2 2026: $28MQ3 2026: $29M
Q4 2023: $13MQ1 2024: $15MQ2 2024: $15MQ3 2024: $17MQ4 2024: $19MQ1 2025: $20MQ2 2025: $21MQ3 2025: $23MQ4 2025: $25MQ1 2026: $26MQ2 2026: $28MQ3 2026: $29M
QuarterRevenueYoY
Q3 2026$29.3M+30%
Q2 2026$28.1M+33%
Q1 2026$26.5M+29%
Q4 2025$24.8M+34%
Q3 2025$22.6M+31%
Q2 2025$21.2M+43%
Q1 2025$20.5M+38%
Q4 2024$18.5M+41%

CBLL has the edge over UNH on sales, with more consistent year-over-year improvement.

UNH Quarterly Revenue

Q4 2023: $94.4BQ1 2024: $99.8BQ2 2024: $98.9BQ3 2024: $101BQ4 2024: $101BQ1 2025: $110BQ2 2025: $112BQ3 2025: $113BQ4 2025: $113BQ1 2026: $112BQ2 2026: $112BQ3 2026: $113B
Q4 2023: $94.4BQ1 2024: $99.8BQ2 2024: $98.9BQ3 2024: $101BQ4 2024: $101BQ1 2025: $110BQ2 2025: $112BQ3 2025: $113BQ4 2025: $113BQ1 2026: $112BQ2 2026: $112BQ3 2026: $113B
QuarterRevenueYoY
Q3 2026$112.7B-0.4%
Q2 2026$112B+0.4%
Q1 2026$111.7B+2%
Q4 2025$113.2B+12%
Q3 2025$113.2B+12%
Q2 2025$111.6B+13%
Q1 2025$109.6B+9.8%
Q4 2024$100.8B+6.8%

UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.

CBLL Free Cash Flow

Q4 2023: −$7MQ1 2024: −$10MQ2 2024: −$7MQ3 2024: --Q4 2024: −$10MQ1 2025: −$12MQ2 2025: −$8MQ3 2025: −$11MQ4 2025: −$11MQ1 2026: −$19MQ2 2026: −$13MQ3 2026: −$13M
Q4 2023: −$7MQ1 2024: −$10MQ2 2024: −$7MQ3 2024: --Q4 2024: −$10MQ1 2025: −$12MQ2 2025: −$8MQ3 2025: −$11MQ4 2025: −$11MQ1 2026: −$19MQ2 2026: −$13MQ3 2026: −$13M
QuarterFree cash flowYoY
Q3 2026-$13.2M-$1.7M
Q2 2026-$12.9M-$5.3M
Q1 2026-$19.4M-$7.9M
Q4 2025-$11M-$621K
Q2 2025-$7.6M-$344K
Q1 2025-$11.6M-$1.9M
Q4 2024-$10.3M-$3M
Q2 2024-$7.3M+$963K

CBLL has burned cash in almost every quarter: −$56M over the past year, against −$41M the year before.

UNH Free Cash Flow

Q4 2023: −$6.2BQ1 2024: $401MQ2 2024: $5.9BQ3 2024: $13BQ4 2024: $1.5BQ1 2025: $4.6BQ2 2025: $6.3BQ3 2025: $5.1BQ4 2025: $160MQ1 2026: $8.1BQ2 2026: $10.3BQ3 2026: $4.3B
Q4 2023: −$6.2BQ1 2024: $401MQ2 2024: $5.9BQ3 2024: $13BQ4 2024: $1.5BQ1 2025: $4.6BQ2 2025: $6.3BQ3 2025: $5.1BQ4 2025: $160MQ1 2026: $8.1BQ2 2026: $10.3BQ3 2026: $4.3B
QuarterFree cash flowYoY
Q3 2026$4.3B-16%
Q2 2026$10.3B+63%
Q1 2026$8.1B+79%
Q4 2025$160M-89%
Q3 2025$5.1B-61%
Q2 2025$6.3B+6.9%
Q1 2025$4.6B+1037%
Q4 2024$1.5B+$7.6B

UNH has the edge over CBLL on cash generation, producing positive trailing cash flow while its opponent burns cash.

CBLL Total Shares

Q4 2023: 23MQ1 2024: 34MQ2 2024: 34MQ3 2024: 6MQ1 2025: 36MQ2 2025: 36MQ3 2025: 37MQ4 2025: 37MQ1 2026: 38MQ2 2026: 38MQ3 2026: 39M
Q4 2023: 23MQ1 2024: 34MQ2 2024: 34MQ3 2024: 6MQ1 2025: 36MQ2 2025: 36MQ3 2025: 37MQ4 2025: 37MQ1 2026: 38MQ2 2026: 38MQ3 2026: 39M
PeriodChange %Net change
Quarterly+1.2%+468K shares
1 year+4.6%+1.7M shares
3 years+65%+15.2M shares

CBLL has 39M diluted shares, up 4.6% from a year ago.

UNH Total Shares

Q4 2023: 938MQ1 2024: 922MQ2 2024: 928MQ3 2024: 930MQ4 2024: 929MQ1 2025: 918MQ2 2025: 910MQ3 2025: 908MQ4 2025: 911MQ1 2026: 910MQ2 2026: 906MQ3 2026: 902M
Q4 2023: 938MQ1 2024: 922MQ2 2024: 928MQ3 2024: 930MQ4 2024: 929MQ1 2025: 918MQ2 2025: 910MQ3 2025: 908MQ4 2025: 911MQ1 2026: 910MQ2 2026: 906MQ3 2026: 902M
PeriodChange %Net change
Quarterly-0.4%-4M shares
1 year-0.7%-6M shares
3 years-3.6%-34M shares
5 years-5.5%-53M shares
Available history-6.6%-64M shares

UNH has the edge over CBLL on shareholder dilution, with a more favorable share count trend.

CBLL Net Leverage

CBLL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

UNH Net Leverage

Q4 2023: 1.0xQ1 2024: 1.3xQ2 2024: 1.4xQ3 2024: 1.3xQ4 2024: 1.4xQ1 2025: 1.3xQ2 2025: 1.5xQ3 2025: 1.7xQ4 2025: 2.3xQ1 2026: 2.2xQ2 2026: 1.7xQ3 2026: 1.7x
Q4 2023: 1.0xQ1 2024: 1.3xQ2 2024: 1.4xQ3 2024: 1.3xQ4 2024: 1.4xQ1 2025: 1.3xQ2 2025: 1.5xQ3 2025: 1.7xQ4 2025: 2.3xQ1 2026: 2.2xQ2 2026: 1.7xQ3 2026: 1.7x
QuarterNet LeverageStatus
Q3 20261.7xHealthy
Q2 20261.7xHealthy
Q1 20262.2xModerate
Q4 20252.3xModerate
Q3 20251.7xHealthy
Q2 20251.5xHealthy
Q1 20251.3xHealthy
Q4 20241.4xHealthy

UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.

CBLL Weekly Momentum

MetricValueStatus
RSI65.5Neutral
Stochastic80.0Neutral

CBLL's weekly RSI is 65 (neutral) and its Stochastic is 80 (neutral).

UNH Weekly Momentum

MetricValueStatus
RSI56.4Neutral
Stochastic60.0Neutral

UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).

CBLL PE vs Healthcare Sector

CBLL has no meaningful PE right now: it lost money over the past year.

UNH PE vs Healthcare Sector

MetricUNHSector medianRelative
PE23x26x11% below
PE %472918 pts above

UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.

CBLL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$25.34% above
20 week MA$22.915% above
50 week MA$21.025% above
100 week MA$19.038% above

CBLL has stronger trend alignment. CBLL is above 4 of 4 weekly averages versus UNH above 4 of 5.

UNH Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$394.22.8% above
20 week MA$400.51.2% above
50 week MA$361.212% above
100 week MA$376.07.8% above
200 week MA$446.69.3% below

UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.

CBLL Yearly ROI

YearStart priceEnd priceROI
2024$25.0$26.5+5.8%
2025$26.5$21.3-19%
2026 YTD$21.3$26.4+24%

CBLL has the edge over UNH on returns for 2026, with the stronger performance.

UNH Yearly ROI

YearStart priceEnd priceROI
2020$296.0$340.8+15%
2021$340.8$495.4+45%
2022$495.4$531.3+7.3%
2023$531.3$526.5-0.9%
2024$526.5$510.0-3.1%
2025$510.0$331.8-35%
2026 YTD$331.8$405.1+22%

UNH has finished three years in a row lower, and it's up 22% so far in 2026.

Give your agent the market.

Get API key